Replies to post #249122 on Biotech Values

[jbog]

The RSV season isn't close to beginning and this guy is saying there will be lower hospitalization rates.

Don't you expect the vaccine's will have an effect? The street expects anywhere between $1 and $2 Billion of vaccine sales this year/

[alertmeipp]

$ENTA - target price of $15, so we are talking about 40% upside? And that's not outperform LOL. Analyst target price is just for fun.

And $15 is pretty much the net cash value, so he is not saying the current trend is reducing ED-235 partnerability. He is saying ENTA's royalty steam, pipeline and option value on $PFE lawsuit worth ZERO.